Former CEO, board member and a member of the strategy committee of sanofi-aventis. He is Chairman Elect PhRMA in the United States. After beginning his career at PriceWaterhouseCoopers, between 1988 and 2008, he acquired broad international experience in Europe, in the United States and in Canada with the GlaxoSmithKline (GSK) company. In his last position, he was President, Pharmaceutical Operations North America, a member of the board and Co-Chairman of the Portfolio Management Board. He is a graduate of the Queens University (Ontario, Canada) and a certified public accountant.
For a reasonably open world
